Your browser doesn't support javascript.
loading
Responses are durable for up to 5 years after completion of peginterferon alfa-2a treatment in hepatitis B e antigen-positive patients.
Chuang, W-L; Jia, J; Chan, H L Y; Han, K-H; Tanwandee, T; Tan, D; Chen, X; Gane, E; Piratvisuth, T; Chen, L; Xie, Q; Sung, J J-Y; Messinger, D; Wat, C; Bakalos, G; Liaw, Y F.
Afiliação
  • Chuang WL; Kaohsiung, Taiwan.
  • Jia J; Beijing, China.
  • Chan HLY; Hong Kong SAR, China.
  • Han KH; Seoul, Korea.
  • Tanwandee T; Bangkok, Thailand.
  • Tan D; Changsha, China.
  • Chen X; Beijing, China.
  • Gane E; Grafton, New Zealand.
  • Piratvisuth T; Hat-Yai, Thailand.
  • Chen L; Shanghai, China.
  • Xie Q; Shanghai, China.
  • Sung JJ; Hong Kong SAR, China.
  • Messinger D; Mannheim, Germany.
  • Wat C; Welwyn Garden City, UK.
  • Bakalos G; Basel, Switzerland.
  • Liaw YF; Taipei, Taiwan.
Aliment Pharmacol Ther ; 47(9): 1306-1316, 2018 May.
Article em En | MEDLINE | ID: mdl-29520872

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Polietilenoglicóis / Interferon-alfa / Hepatite B Crônica / Resposta Viral Sustentada Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Polietilenoglicóis / Interferon-alfa / Hepatite B Crônica / Resposta Viral Sustentada Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article